Abstract
There is a paucity of research and a lack of necessary guidance for proper characterization of pulmonary hypertension presenting in patients with connective tissue disease and interstitial lung disease, specifically related to differentiating between WHO group 1 pulmonary arterial hypertension and WHO group 3 pulmonary hypertension due to lung disease and/or hypoxia. Without a mechanism for proper differentiation of the type of pulmonary hypertension that exists, appropriate management of this subset of individuals is particularly challenging. This review presents the pertinent research that exist regarding the intricacies of this disease state with the goal of providing improved guidance as to who may benefit from screening, diagnosis, treatment in a facility with expertise in the field, and referral for lung transplant.
Keywords: Pulmonary hypertension, pulmonary arterial hypertension, interstitial lung disease, connective tissue disease, parenchymal lung disease, lung transplant.
Current Respiratory Medicine Reviews
Title:Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
Volume: 11 Issue: 2
Author(s): Lana Melendres-Groves, Rodrigo Vazquez-Guillamet and Gundeep Dhillon
Affiliation:
Keywords: Pulmonary hypertension, pulmonary arterial hypertension, interstitial lung disease, connective tissue disease, parenchymal lung disease, lung transplant.
Abstract: There is a paucity of research and a lack of necessary guidance for proper characterization of pulmonary hypertension presenting in patients with connective tissue disease and interstitial lung disease, specifically related to differentiating between WHO group 1 pulmonary arterial hypertension and WHO group 3 pulmonary hypertension due to lung disease and/or hypoxia. Without a mechanism for proper differentiation of the type of pulmonary hypertension that exists, appropriate management of this subset of individuals is particularly challenging. This review presents the pertinent research that exist regarding the intricacies of this disease state with the goal of providing improved guidance as to who may benefit from screening, diagnosis, treatment in a facility with expertise in the field, and referral for lung transplant.
Export Options
About this article
Cite this article as:
Melendres-Groves Lana, Vazquez-Guillamet Rodrigo and Dhillon Gundeep, Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease, Current Respiratory Medicine Reviews 2015; 11 (2) . https://dx.doi.org/10.2174/1573398X11666150619183225
DOI https://dx.doi.org/10.2174/1573398X11666150619183225 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammation, Oxidative Stress and Metabolic Syndrome: Dietary Modulation
Current Vascular Pharmacology Elevation of E-Selectin Concentrations may Correlate with Potential Endothelial Dysfunction in Individuals with Hypopituitarism During Therapy with Growth Hormone
Current Neurovascular Research Phytoestrogen Genistein and Its Pharmacological Interactions with Synthetic Endocrine-Active Compounds
Current Pharmaceutical Design Molecular Dissection of Renal Ischemia-Reperfusion: Oxidative Stress and Cellular Events
Current Medicinal Chemistry Measurement of Physical Changes in the Myocardium for Development of Novel Methods for Diagnosing Ischemia
Current Cardiology Reviews Statins in the Prevention of Cardiovascular Events in Patients with Renal Failure
Cardiovascular & Hematological Disorders-Drug Targets An Overview on COVID-19 and its Effect on Cardiovascular Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Emerging Therapies for Type 2 Diabetes
Current Drug Therapy Blood Pressure and Childhood Obesity
Current Hypertension Reviews Metabolic Syndrome and Aging: Calcium Signaling as Common Regulator
Current Diabetes Reviews Flavonoids and Linderone from Lindera oxyphylla and their Bioactivities
Combinatorial Chemistry & High Throughput Screening Resistin and Oxidative Stress as Markers of Atherosclerosis in Obstructive Sleep Apnea
Current Respiratory Medicine Reviews Anti-VEGF Compounds in the Treatment of Neovascular Age Related Macular Degeneration
Current Drug Targets Mechanism and Anticancer Activity of the Metabolites of an Endophytic Fungi from Eucommia ulmoides Oliv
Anti-Cancer Agents in Medicinal Chemistry The Role of COX-2 in Heart Pathology
Cardiovascular & Hematological Agents in Medicinal Chemistry Surrogates of Insulin Sensitivity and Indices of Cardiometabolic Profile in Obesity
Current Vascular Pharmacology Development of a Novel Nanocomposite Based on Reduced Graphene Oxide/Chitosan/Au/ZnO and Electrochemical Sensor for Determination of Losartan
Current Analytical Chemistry Familial Combined Hyperlipidaemia: Under - Defined and Under - Diagnosed?
Current Vascular Pharmacology Role of Renin-Angiotensin-Aldosterone System in Metabolic Syndrome and Obesity-related Hypertension
Current Hypertension Reviews Sunitinib in the Treatment of Thyroid Cancer
Current Medicinal Chemistry